J&J studies find icotrokinra more effective than deucravacitinib for psoriasis J&J studies find icotrokinra more effective than deucravacitinib for psoriasis Post Contentjnj, bmyRead More You might also be interested in reading EssilorLuxottica gives H1 results. September 17, 2025 In Mainstream ← Previous post Next post →